Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 10—October 2017
Research Letter

Unrecognized Subclinical Infection with Tickborne Encephalitis Virus, Japan

Kentaro Yoshii, Reiji Kojima, and Hiroshi NishiuraComments to Author 
Author affiliations: Hokkaido University, Sapporo, Japan (K. Yoshii); Japan Self-Defense Forces Sapporo Hospital, Sapporo (R. Kojima); University of Yamanashi, Yamanashi, Japan (R. Kojima); Hokkaido University, Sapporo (H. Nishiura)

Main Article

Table

Neutralizing antibody titers against TBEV and JEV among members of the Japan Self-Defense Forces screened in early 2017*

Patient age, y Received tick bite in previous 10 y Antibody titer†
TBEV
 JEV
42 3 times 80 <20
48 1 time 40 <20

*JEV, Japanese encephalitis virus; TBEV, tickborne encephalitis virus.
†Neutralizing titer was defined as the reciprocal of the highest dilution of serum.

Main Article

Page created: September 19, 2017
Page updated: September 19, 2017
Page reviewed: September 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external